Isotopes & agents
Every radionuclide, every labelled molecule, every target, indication and trial. One page each, plain English first.
Half-life, what it emits, how it is made, how tight supply is.
Therapeutic radiopharmaceuticals and diagnostic tracers, approved and in trials.
PSMA, SSTR2, FAP and the rest: what the ligand is aimed at.
Chelators, generators, production routes, scanners, dosimetry.
What these agents are used for, in oncology, neurology, cardiology and infection.
The areas of the field, from molecular imaging to alpha therapy and supply.
Landmark and current trials, with results where they have reported.
Theranostic pairs, combinations, sequences and the pairs to avoid.
History to horizon for each part of the field.
What each technology cannot exist without, drawn in layers.
Every agent with a 3D structure, filterable by modality, isotope and target.
The constraints holding the field back, and the ideas that could break each one.
Hypotheses and fixes, each with a proposed test.
Physics, chemistry, dosimetry, safety and regulation, in plain words.
The open databases and standards the field runs on.
The biology behind the targets, drawn and explained.